Clinical trial
UPRISE (Urine Prostate Screening Integrated With MRI for Prostate Cancer Early Detection)
NCT07526545 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- UPRISE (Urine Prostate Screening Integrated With MRI for Prostate Cancer Early Detection)
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- March 1, 2030
- Enrollment
- 800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate carcinoma